Filter
204
Filtered Results: 204
Text search:
Severe
Malaria
Observatory
Featured
Recommendations
16
New Publications
58
Language
Document type
No document type
91
Studies & Reports
69
Strategic & Response Plan
21
Guidelines
8
Situation Updates
4
Training Material
3
Resource Platforms
3
Manuals
2
Fact sheets
2
Online Courses
1
Countries / Regions
Global
18
Venezuela
12
Africa
11
Liberia
10
Latin America and the Carribbean
7
Sierra Leone
6
East and Southern Africa
6
Rwanda
5
Syria
5
Malawi
5
South–East Asia Region
5
Congo, Democratic Republic of
4
West and Central Africa
4
Western and Central Europe
4
Namibia
4
Myanmar / Burma
4
Guinea
3
Mozambique
3
Tanzania
3
Middle East and North Africa
3
Sudan
3
Pakistan
3
Kenya
2
Cameroon
2
Iran
2
Nigeria
2
Burkina Faso
2
Jordan
2
Saudi Arabia
2
Lebanon
2
Bangladesh
2
Yemen
2
Zambia
2
Iraq
2
Nepal
1
Turkey
1
Ghana
1
Chile
1
Albania
1
Senegal
1
Afghanistan
1
Peru
1
Morocco
1
Qatar
1
Philippines
1
Cambodia
1
Asia
1
Eastern Europe and Central Asia
1
Paraguay
1
Tunisia
1
South Africa
1
Eastern Europe
1
Papua New Guinea
1
Moldova
1
Djibouti
1
Egypt
1
Greece
1
Palestine
1
Georgia
1
Libya
1
Botswana
1
South Sudan
1
Indonesia
1
Somalia
1
India
1
Madagascar
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
86
Public Health
13
Women & Child Health
12
Clinical Guidelines
10
Key Resources
8
Capacity Building
3
Toolboxes
Planetary Health
22
Global Health Education
14
NTDs
11
Malaria
11
COVID-19
9
TB
8
HIV
7
Mental Health
6
AMR
6
Disability
4
Ebola & Marburg
4
Health Financing Toolbox
4
Rapid Response
3
Caregiver
3
NCDs
3
Conflict
2
Refugee
1
Natural Hazards
1
Cholera
1
Pharmacy
1
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
The information provided here can be used to understand the current situation, increase attention to preterm births in Rwanda and to inform dialogue and action among stakeholders. Data can be used to identify the most important risk factors to target and gaps in care in order to identify and impleme...
The Compendium brings together for the first time key consensus-based policy recommendations and guidance to improve the delivery of proven interventions to women and children. The user-friendly format incorporates icons and tabs to present key health-related policies that support the delivery of es...
Climate change and health vulnerability and adaptation assessment
In 2013 the World Health Organization (WHO) published the report Protecting health from climate change:
vulnerability and adaptation assessment. The aim was to provide basic and flexible guidance on conducting national or subnati...
Summary of research into the consequences of the Ebola outbreak for children and communities in Liberia and Sierra Leone
This policy brief presents a summary of current evidence on vulnerability to TB and proposes interventions for equitable, person-centred, and human rights-based TB prevention and care. It aligns with WHO policies and guidance on TB prevention and screening, management of TB and comorbidities, access...
The Lancet Countdown is an international collaboration that independently monitors the health consequences of a changing climate. Publishing updated, new, and improved indicators each year, the Lancet Countdown represents the
consensus of leading researchers from 43 academic institutions and UN ag...
Atlas of African Health Statistics 2022: Health situation analysis of the WHO African Region
Since 2019, we have been implementing Phase 2 of the regional Transformation Agenda, which informs and aligns with the global WHO Transformation, to ensure WHO is accountable, driven by re- sults and provid...
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
Actualmente, en el mundo, el cáncer produce millones de muertes al año, generando altos costos económicos y sociales, tanto por los valores asignados al tratamiento, como por el compromiso que genera en la productividad laboral de las personas directamente afectadas y de su entorno familiar y/o c...
Joule 5, 2687–2714 October 20, 2021 Cell Press
This is the fifteenth edition of the lecture notes. They were first published in 1987 as a summary of the material used in the biannual epilepsy teaching weekend organised under the auspices of the UK Chapter of the International League against Epilepsy.
(Lecture series consist of a total of 59 cha...
